↓ Skip to main content

Cochrane Database of Systematic Reviews

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
4 news outlets
blogs
2 blogs
policy
2 policy sources
twitter
85 X users
patent
1 patent
facebook
3 Facebook pages
wikipedia
8 Wikipedia pages

Citations

dimensions_citation
473 Dimensions

Readers on

mendeley
709 Mendeley
Title
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd007115.pub3
Pubmed ID
Authors

Michael PT Lunn, Richard AC Hughes, Philip J Wiffen

Abstract

Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy. A number of trials have been conducted to investigate the use of duloxetine in neuropathic and nociceptive painful conditions. This is the first update of a review first published in 2010.

X Demographics

X Demographics

The data shown below were collected from the profiles of 85 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 709 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 <1%
Switzerland 1 <1%
Brazil 1 <1%
Canada 1 <1%
Denmark 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 700 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 98 14%
Student > Bachelor 83 12%
Researcher 80 11%
Student > Postgraduate 57 8%
Other 55 8%
Other 144 20%
Unknown 192 27%
Readers by discipline Count As %
Medicine and Dentistry 245 35%
Nursing and Health Professions 65 9%
Pharmacology, Toxicology and Pharmaceutical Science 34 5%
Psychology 33 5%
Neuroscience 25 4%
Other 90 13%
Unknown 217 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 114. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2023.
All research outputs
#369,059
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#630
of 11,499 outputs
Outputs of similar age
#3,439
of 319,030 outputs
Outputs of similar age from Cochrane database of systematic reviews
#12
of 230 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,030 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 230 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.